Merck KGaA (FRA: MRK)‘s stock had its “sell” rating reaffirmed by research analysts at Independent Research GmbH in a report released on Wednesday. They currently have a $123.68 (€95) target price on the stock.

Merck KGaA traded up 3.54% on Wednesday, hitting €106.50. Merck KGaA has a 1-year low of €72.00 and a 1-year high of €103.00.

MRK has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Merck KGaA in a research note to investors on Thursday. They now have a $125.97 price target on the stock. Separately, analysts at AlphaValue reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Thursday, November 29th. They now have a $113.64 price target on the stock. Finally, analysts at AlphaValue reiterated a “sell” rating on shares of Merck KGaA in a research note to investors on Tuesday, November 20th. They now have a $110.51 price target on the stock.

.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.